In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

The free consultation period for this content is over.

It is now only available year-round to ESC Professional Members, Fellows of the ESC, and Young combined Members

Comparison of myocardial ischemia assessed by contrast-flow quantitative flow ratio (cQFR) and by stress MRI in patients with stable coronary artery disease

Session Poster Session 3

Speaker Karsten Lenk

Event : ESC Congress 2019

  • Topic : coronary artery disease, acute coronary syndromes, acute cardiac care
  • Sub-topic : Coronary Circulation, Flow, and Flow Reserve
  • Session type : Poster Session

Authors : K Lenk (Leipzig,DE), V Schwarzbach (Leipzig,DE), M Antoniadis (Leipzig,DE), M Blum (Leipzig,DE), A Hagendorff (Leipzig,DE), D Lavall (Leipzig,DE), U Laufs (Leipzig,DE)

K Lenk1 , V Schwarzbach1 , M Antoniadis1 , M Blum1 , A Hagendorff1 , D Lavall1 , U Laufs1 , 1Leipzig University Hospital - Leipzig - Germany ,


Background:Contrast-flow quantitative flow ratio (cQFR) is a new technology for evaluation of coronary stenosis. cQFR allows to derive the fractional flow reserve (FFR) from coronary angiograms. Based on a three dimensional coronary model, FFR is calculated from computational fluid dynamics. Head to head comparisons with FFR showed an overall diagnostic accuracy of 85%. cQFR does not require coronary wires or hyperemia.  However, the ability of cQFR to detect myocardial ischemia is unknown. Therefore, the aim of this study was to evaluate the relationship between cQFR and myocardial ischemia assessed by stress magnetic resonance imaging (stress MRI).

Methods: cQFR analysis was performed in patients selected from the hospital database who received stress MRI and coronary angiography. A relevant ischemia on stressMRI was defined as a perfusion deficit in = 2 of 16 segments. The cQFR was based on 3-dimensional quantitative coronary angiography (3D-QCA) using the QAngio XA 3D 1.1, Medis Medical Imaging System, Leiden, The Netherlands. Two blinded investigators analysed all 3 main coronary vessels of each patient measuring diameter stenosis (DS), area stenosis(AS) and cQFR. A cQFR of =0.8 was considered abnormal. The primary endpoint was sensitivity and specificity of cQFR using stress MRI as a reference standard.

Results: 125 vessels of 53 patients could be fully analysed by cQFR (78.6%). The sensitivity of cQFR in detecting significant epicardial stenoses of coronary vessels with documented ischemia in stress MRI was 75%, the specificity was 87%. The 3D-QCA-derived diameter stenoses and area stenoses in vessels with positive stress MRI were significantly higher than in vessels without ischemia (see Table 1). 

Conclusion: The analysis reveals a high correlation between relevant coronary stenosis measured by cQFR and ischemic areas detected by stress MRI. Differences between the two methods are plausible because stress MRI detects ischemia due to other reasons than epicardial stenosis. Further randomized studies are mandatory to verify the prognostic significance of the cQFR measurements.

Total (n=125)

Ischemia (n=32)

no Ischemia (n=93)


DS [%]

42.3 (28.3-53.1)

57.1 (47-68.5)

37.7 (27.6-45.1)


AS [%]

51.8 (32.4-69.7)

68.9 (56.8-85.9)

46.5 (29.7-62.7)


Table 1. Means of diameter stenosis (DS) und area stenosis (AS) with interquartile range (IQR)

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are